# DKA Capital

> DKA Capital is a VC fund in Copenhagen backing Biotechnology and Medical. See 6 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Copenhagen, Denmark
- Total investments: 6
- Last investment: Jan 2021
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.dankap.dk

DKA Capital (formerly Dansk Kapitalanlæg) is a well-established Danish PE fund investing in and developing knowledge-intensive growth companies with a global potential with the aim of creating long term sustainable value.Since DKA Capital was founded in 1984, we have completed 180 investments and 175 exits of which 21 were in the form ofIPO's (Initial Public Offerings). This makes us one of the largest and most experienced investors in Denmark.The specialisation process in DKA Capital was initiated in 2006 and in 2011 the management of DKA Capital together Norwegian Argentum acquired 75% of the fund DKA II.DKA Capital has through DKA II 5 companies in its portfolio. DKA II is owned by the management of DKA Capital, Argentum, Nordea Liv & Pension and Danica Pension. We believe in direct and constructive communication leaving no doubt to what DKA Capital stands for or what we would like to achieve during our period of ownership. Together with the companies we execute professionally and create sense-of-urgency. DKA Capital's aim is to be strategic and intelligent change of ownership. And we want to maintain our position as one of the most credible partners for knowledge-intensive growth companies.We invest in knowledge intensive companies with international growth opportunities. During the recent years we have marked ourselves as one of Denmark's leading funds within this field.

## Contacts

5 contacts available for DKA Capital. Shizune tracks 2 team members at DKA Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/dka-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 50% |
| Medical | 2 | 33% |
| Therapeutics | 2 | 33% |
| SaaS | 1 | 17% |
| Software | 1 | 17% |

13 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 3 | 50% |
| Series A | 1 | 17% |
| Funding Round | 1 | 17% |
| Debt Financing | 1 | 17% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Denmark | 3 | 50% |
| Germany | 2 | 33% |
| Sweden | 1 | 17% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Jesper Johansen | Partner | 2 | https://shizune.co/investors/profile/jesper-johansen |
| Niels Henrik Rasmussen | Co-Founder | 0 | https://shizune.co/investors/profile/niels-henrik-rasmussen-ec74 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| CanopyLAB | CanopyLAB is an educational technology company located in Hvidovre, Greater Copenhagen, Denmark. We have built an AI-powered social learning platform for corporate training. Through personalization our platform enables all learners to realize their potential in a way that is fast, fun and future-proof. We call it "The Future of Learning-Delivered Today".We work on two verticals:1. The Canopy A social learning platform powered by AI A research-based social learning platform for developing competencies through individualized and adaptive learning experiences. It is designed with an integrated social network structure to enhance collaborative learning and built on strong Nordic learning principles.2. The LAB A learning community with provocative content Join our global learning community for youth. Take free courses, exchange ideas, gain new knowledge and practice competencies offered by 100 + pioneering NGOs in controversial and often neglected topics such as sexuality, sexual & reproductive rights, climate action, health, and the SDGs.CanopyLAB acquired Peruvian publishing startup Yopublico in April 2020. | $1.5M | Debt Financing | Jan 26, 2021 |  |
| Hymite | Hymite is a venture funded product company bringing to market the next generation packaging platform for use with High Power (HP) / Ultra-high Brightness (UHB) LEDs. Hymite's Engineered Silicon (Si) package platform delivers new levels of performance and value to their customers developing products for Solid State Lighting applications. | $11.5M | Series B | Jan 11, 2007 |  |
| NsGene | NsGene is a Danish Biotech company located in the Medicon Valley region. The Company is committed to developing novel biological products for the treatment of neurological diseases and is focusing on multiple indications with high unmet needs, including Alzheimer's disease, epilepsy, neuropathic pain and Parkinson's disease. | $5.1M |  | May 02, 2005 |  |
| Direct Conversion | Direct Conversion provides detectors into imaging systems that are used across the globe | $23.3M | Series B | Jul 01, 2002 |  |
| Develogen AG | Develogen is a biology-driven drug discovery company that is engaged in the development of therapies for diabetes and obesity. The company was founded in 1995 and is based in Georgia, United States. | $43.9M | Series B | Apr 18, 2001 |  |
| HepaVec AG | HepaVec AG is a privately held biotechnology company, focused on the development of novel therapeutic products for addressing malignant and genetic liver diseases, and on cell engineering of hepatocytes (liver cells). HepaVec has developed new gene transfer systems (vectors), derivatives of baculovirus and an ovine (sheep) adenovirus (OAV), whichenable efficient and specific delivery of therapeutic genes into human liver cells. In the combat against liver cancer, HepaVec's lead product regulates the cell cycle to selectively drive cancer cells to programmed cell death (apoptosis) and is scheduled to enter a Phase I/II clinical trial in 2000. | $4.4M | Series A | May 08, 2000 |  |

6 of 6 investments shown.

## Co-investors
- [Techno Venture Management](https://shizune.co/investors/profile/tvm-techno-venture-management) — VC Fund, 2 deals together
- [Vaekstfonden](https://shizune.co/investors/profile/v%C3%A6kstfonden) — VC Fund, 2 deals together
- [Abingworth](https://shizune.co/investors/profile/abingworth-management) — VC Fund, 1 deal together
- [Alafi Capital](https://shizune.co/investors/profile/alafi-capital) — VC Fund, 1 deal together
- [Concordia](https://shizune.co/investors/profile/concordia-7fb2) — VC Fund, 1 deal together
- [Deutsche Venture Capital](https://shizune.co/investors/profile/deutsche-venture-capital) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [Vaekstfonden](https://shizune.co/investors/profile/v%C3%A6kstfonden) — VC Fund
- [PSV](https://shizune.co/investors/profile/preseed-innovation) — VC Fund
- [Seed Capital](https://shizune.co/investors/profile/seed-capital) — VC Fund

## Featured in investor lists
- [Health Care Investors in Denmark](https://shizune.co/investors/health-care-investors-denmark)
- [Health Care VC Funds in Denmark](https://shizune.co/investors/health-care-vc-funds-denmark)
- [Biotech VC Funds in Denmark](https://shizune.co/investors/biotech-vc-funds-denmark)
- [Biotechnology VC Funds in Denmark](https://shizune.co/investors/biotechnology-vc-funds-denmark)

## FAQ

### What does DKA Capital invest in?

DKA Capital invests primarily in Biotechnology, Medical and Therapeutics startups, most often at Series B and Series A stage. Most of the 6 investments tracked by Shizune back companies in Denmark. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact DKA Capital?

Public channels for DKA Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at DKA Capital?

The team at DKA Capital includes Jesper Johansen (Partner) and Niels Henrik Rasmussen (Co-Founder). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co